Gliomas in patients with neurofibromatosis type 1

References

• Friedman JM, Riccardi VM. Clinical and epidemiological features. In: Neurofibromatosis: Phenotype, Natural History and Pathogenesis (3rd Edition). Friedman JM, Gutmann DH, MacCollin M et al. (Eds). The Johns Hopkins University Press, Baltimore, USA and London, UK (1999).
   Google Scholar
• NIH Consensus Development Conference. Neurofibromatosis. Arch. Neurol.45, 575–578 (1988).
   PubMed Web of Science ®Google Scholar
• Gutmann DH, Aylsworth A, Carey JC et al. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA278(1), 51–57 (1997).
   PubMed Web of Science ®Google Scholar
• Guillamo JS, Creange A, Kalifa C et al. Prognostic factors of CNS tumors in neurofibromatosis 1(NF1): a retrospective study of 104 patients. Brain126, 152–160 (2003).
   PubMed Web of Science ®Google Scholar
• Matsui I, Taimura M, Kobayashi N et al. Neurofibromatosis type 1 and childhood cancer. Cancer72, 2746–2754 (1993).
   PubMed Web of Science ®Google Scholar
• Korf BR. Neurofibromas and malignant tumors of the peripheral nerve sheath. In: Neurofibromatosis: Phenotype, Natural History and Pathogenesis (3rd Edition). Friedman JM, Gutmann DH, MacCollin M et al. (Eds). The Johns Hopkins University Press, Baltimore, USA and London, UK (1999).
   Google Scholar
• Korf BR. Plexiform neurofibromas. Am. J. Med. Genet.89(1), 31–37 (1999).
   PubMed Web of Science ®Google Scholar
• Ferner RE, Gutmann DH. International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res.62(5), 1573–1577 (2002).
   PubMed Web of Science ®Google Scholar
• Listernick R, Charrow J, Greenwald M et al. Optic gliomas in children with neurofibromatosis type 1. J. Pediatr.114, 788–792 (1989).
   PubMed Web of Science ®Google Scholar
• Listernick R, Charrow J, Greenwald M et al. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J. Pediatr.125, 63–66 (1994).
   PubMed Web of Science ®Google Scholar
• Gutmann DH, Rasmussen SA, Wolkenstein P et al. Gliomas presenting after age 10 in individuals with neurofibromatosis type 1 (NF1). Neurology59, 759–761 (2002).
   PubMed Web of Science ®Google Scholar
• Leonard JR, Perry A, Rubin JB et al. The role of biopsy in the diagnosis of glioma in individuals with neurofibromatosis-1. Neurology67, 1509–1512 (2006).
   PubMed Web of Science ®Google Scholar
• Listernick R, Louis, DN, Packer RJ et al. Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Task Force. Ann. Neurol.41, 143–149 (1997).
   PubMed Web of Science ®Google Scholar
• Listernick R, Ferner R, Liu GT et al. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations. Ann. Neurol.61, 189–198 (2007).
   PubMed Web of Science ®Google Scholar
• King AA, Listernick R, Charrow J et al. Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome. Am. J. Med. Genet.122A, 95–99 (2003).
   PubMed Web of Science ®Google Scholar
• Listernick R, Ferner RE, Piersall L et al. Late-onset optic pathway tumors in children with neurofibromatosis 1. Neurology63, 1944–1946 (2004).
   PubMed Web of Science ®Google Scholar
• Chateil JF, Sossotte C, Pedespan JM et al. MRI and clinical differences between optic patway tumors in children with and without neurofibromatosis. Br. J. Radiol.74, 24–31 (2001).
   PubMed Web of Science ®Google Scholar
• Rodriguez FJ, Perry A, Gutmann DH et al. Gliomas in neurofibromatosis type 1: a clinicopathologic study of 100 patients. J. Neuropathol. Exp. Neurol.67(3), 240–249 (2008).
   PubMed Web of Science ®Google Scholar
• Habiby R, Silverman B, Listernick R et al. Precocious puberty in children with neurofibromatosis type 1. J. Pediatr.126, 364–367 (1995).
   PubMed Web of Science ®Google Scholar
• Lui GT. Optic gliomas of the anterior visual pathway. Curr. Opin. Ophthalmol.17, 427–431 (2006).
   PubMed Web of Science ®Google Scholar
• Sharif S, Ferner R, Birch JM et al. Second primary tumors in neurofibromatosis 1 patients treated for optic glioma: substantial risks after radiotherapy. J. Clin. Oncol.24(16), 2570–2575 (2006).
   PubMed Web of Science ®Google Scholar
• Ullrich NJ, Robertson R, Knnamon DD et al. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology68(12), 932–938 (2007).
   PubMed Web of Science ®Google Scholar
• Ferner RE, Chauduri R, Bingham J et al. MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment. J. Neurol. Neurosurg. Psychiatry56, 492–495 (1993).
   PubMed Web of Science ®Google Scholar
• De Bella K, Poskitt K, Szudek J et al. Use of ‘unidentified bright objects’ on MRI for diagnosis of neurofibromatosis 1 in children. Neurology54, 1646–1651 (2000).
   PubMed Web of Science ®Google Scholar
• Dalla Via P, Opocher E, Pinello ML et al. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program. Neuro Oncol.9(4), 430–437 (2007).
   PubMed Web of Science ®Google Scholar
• Tow SL, Chandela S, Miller NR et al. Long-term outcome in children with gliomas of the anterior visual pathway. Pediatr. Neurol.28(4), 262–270 (2003).
   PubMed Web of Science ®Google Scholar